Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BHVI1 eye drops
- Development stage
- Phase 2
- Lead developer
- Brien Holden Vision Institute
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
BHVI1 eye drops are an experimental topical ophthalmic formulation developed by Hai Yen Eye Care in collaboration with the Brien Holden Vision Institute (BHVI). The drug is a small molecule solution currently in Phase 2 clinical development for the treatment and control of myopia progression in pediatric patients. While the specific active ingredient of BHVI1 has not been publicly disclosed, the BHVI eye drop series is associated with pharmacological agents known to influence axial eye growth, such as atropine and 7-methylxanthine. In clinical studies, BHVI1 is being evaluated as a monotherapy and in combination with BHVI2 to determine its efficacy in reducing the annual rate of myopia progression compared to standard spectacles.
- Other names
- BHVI1 eye dropsBHVI-1 eye dropsBHVI 1 eye drops
02
Targets
mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on BHVI1 eye drops.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BHVI1 eye drops.